Chiu-Ching Kao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chiu-Ching Kao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chia-Hsuan Chou
GenMont Biotech Incorporation
1 shared publication - Chou-Wen Lin
Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Liuo-Jia, Tainan 734, Taiwan
1 shared publication - Chun-Keung Yu
Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC
1 shared publication - Chung-Dann Kan
Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan
1 shared publication - Hsiao Chang Chan
Epithelial Cell Biology Research Center, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
1 shared publication - Hui-Chun Lin
Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan
1 shared publication
Latest Publications
- Open Access
- 12 July 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (7) , 1028
Progenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children
Human cardiac progenitor cells isolated from the same host may have advantages over other sources of stem cells. The aim of this study is to establish a new source of human progenitor cells collected from a waste product, pericardiac effusion fluid, after open-heart surgery in children with congenital heart diseases. The fluid was collected every 24 h for 2 days after surgery in 37 children. Mononuclear cells were isolated and expanded in vitro. These pericardial effusion-derived progenitor cells (PEPCs) exhibiting cardiogenic lineage markers, were highly proliferative and enhanced angiogenesis in vitro. Three weeks after stem cell transplantation into the ischemic heart in mice, cardiac ejection fraction was improved significantly without detectable progenitor cells. Gene expression profiles of the repaired hearts revealed activation of several known repair mechanisms including paracrine effects, cell migration, and angiogenesis. These progenitor cells may have the potential for heart regeneration.
- 12 July 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (7) , 1028
Open AccessProgenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children
Human cardiac progenitor cells isolated from the same host may have advantages over other sources of stem cells. The aim of this study is to establish a new source of human progenitor cells collected from a waste product, pericardiac effusion fluid, after open-heart surgery in children with congenital heart diseases. The fluid was collected every 24 h for 2 days after surgery in 37 children. Mononuclear cells were isolated and expanded in vitro. These pericardial effusion-derived progenitor cells (PEPCs) exhibiting cardiogenic lineage markers, were highly proliferative and enhanced angiogenesis in vitro. Three weeks after stem cell transplantation into the ischemic heart in mice, cardiac ejection fraction was improved significantly without detectable progenitor cells. Gene expression profiles of the repaired hearts revealed activation of several known repair mechanisms including paracrine effects, cell migration, and angiogenesis. These progenitor cells may have the potential for heart regeneration.